Alliance to Improve Detection of Cancer
|
By HospiMedica staff writers Posted on 01 Nov 2000 |
In a strategic alliance aimed at improving the detection of cancer, Eastman Kodak Company (Rochester, NY, USA) plans to integrate computer aided detection (CAD ) software from R2 Technology (Los Altos, CA, USA) into its computed radiography (CR) and digital radiography (DR) systems.
R2 Technology uses pattern recognition algorithms to mark areas with subtle characteristics of specific disease states so radiologists can study those areas in greater detail, thereby enabling them to identify early-stage cancers. The company's ImageChecker System is based on this technology and is the only CAD system to be cleared by the U.S. Food and Drug Administration (FDA) for breast cancer screening. For every 1,000 cancers currently detected by mammography, R2 Technology reports that use of the ImageChecker could result in early detection of an additional 20,500 breast cancers.
Kodak and R2 Technology will work together to develop new applications for CAD technology in conjunction with a variety of imaging modalities. One field of interest is lung cancer, where currently only about 15% of cancers are found in the early stages because the disease is difficult to detect then. In the United States alone, an estimated 156,900 people will die of the disease in the year 2000.
R2 Technology uses pattern recognition algorithms to mark areas with subtle characteristics of specific disease states so radiologists can study those areas in greater detail, thereby enabling them to identify early-stage cancers. The company's ImageChecker System is based on this technology and is the only CAD system to be cleared by the U.S. Food and Drug Administration (FDA) for breast cancer screening. For every 1,000 cancers currently detected by mammography, R2 Technology reports that use of the ImageChecker could result in early detection of an additional 20,500 breast cancers.
Kodak and R2 Technology will work together to develop new applications for CAD technology in conjunction with a variety of imaging modalities. One field of interest is lung cancer, where currently only about 15% of cancers are found in the early stages because the disease is difficult to detect then. In the United States alone, an estimated 156,900 people will die of the disease in the year 2000.
Latest Business News
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read moreCritical Care
view channelGraphene-Based Material Selectively Eliminates Bacteria While Sparing Human Cells
Drug-resistant bacterial infections continue to complicate wound management and device-associated care, where persistent contamination raises morbidity and costs. Safer, fabric‑integrated antimicrobials... Read more
Dried Platelet Biologic Reduces Hemorrhage After Traumatic Brain Injury
Traumatic brain injury (TBI) triggers immediate intracranial bleeding and days-later cerebral edema that can rapidly worsen neurological injury. Effective drug options to curb these processes are limited,... Read more
Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection
Remote cardiac monitoring requires comfort, wearability, and adherence to gather electrocardiogram data for clinical review. Mailing devices back for data processing can delay review. Faster insights,... Read moreSurgical Techniques
view channel
Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions
Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Transcatheter Venous Arterialization Improves Outcomes in No-Option Limb Ischemia Patients
Chronic limb-threatening ischemia (CLTI) is an advanced stage of peripheral artery disease in which plaque narrows leg arteries and severely restricts blood flow, leading to pain, nonhealing wounds, and... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more







